Navigation Links
ANA598 Demonstrates Potent Antiviral Activity at all Dose Levels in Completed Phase Ib Study in Hepatitis C Patients
Date:4/23/2009

ted at all three doses in this study is very encouraging for the prospects of ANA598 when used in combination with other HCV agents. With the successful conclusion of this study in patients and the 14-day study in healthy volunteers, the positive 13-week animal toxicology results and ongoing manufacturing activities, the ANA598 program continues on track to be ready for Phase II in mid-2009."

The Phase Ib study was a randomized, double-blind, placebo-controlled, multiple ascending dose trial conducted to evaluate the safety, tolerability and antiviral activity of orally administered ANA598 in treatment-naive patients with chronic HCV genotype 1 infection. Patients were treated with ANA598 capsules (or matching placebo) at doses of 200 mg, 400 mg or 800 mg bid for three days. 35 patients participated in the study, with 11 receiving 200 mg bid, eight receiving 400 mg bid, eight receiving 800 mg bid and eight receiving placebo (with none of the patients receiving placebo showing an end of treatment response greater than 0.2 log10 reduction in viral load). Viral load at Day 4 (12 hours after the last dose) was compared to baseline HCV RNA levels.

"We're very pleased with the antiviral activity and safety of ANA598 in this study," commented James Freddo, M.D., Senior Vice President, Drug Development and Chief Medical Officer. "We believe the data continue to position ANA598 as a leading non-nucleoside polymerase inhibitor in development for the treatment of HCV, and we look forward to investigating ANA598 in longer-term studies in combination with current standard of care."

ANA598 Program Update

Anadys continues to make progress on all aspects of the ANA598 program, including toxicology, manufacturing and a recently completed 14-day clinical study in healthy volunteers. The Company reiterates its expectation for the program to be ready mid-year for the first Phase II study of ANA598 in combination wi
'/>"/>

SOURCE Anadys Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in HCV-Infected Patients
2. Anadys Pharmaceuticals Announces Single Dose Safety and Pharmacokinetics Results for ANA598 in Healthy Volunteers
3. Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV Patients
4. Anadys Pharmaceuticals Initiates Phase I Clinical Trial of ANA598
5. Anadys Pharmaceuticals Presents Data on ANA598, a Non-Nucleoside Inhibitor of the HCV Polymerase, at the 21st International Conference on Antiviral Research
6. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection
7. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
8. Study Demonstrates Restylane(R) Effect Lasted 18 Months in 97% of Patients With One Repeat Injection
9. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
10. Video: Tasigna(R) Demonstrates Rapid Response as Initial Therapy in Life-Threatening Form of Leukemia
11. Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... Instrument Manufacturing Industry in the U.S. ... Edition] ,, http://www.reportlinker.com/p0167745/Surgical-and-Medical-Instrument-Manufacturing-Industry-in-the-US-and-its-International-Trade-[Q4-2009-Edition].html ... of Surgical and Medical Instrument Manufacturing ...
(Date:12/15/2009)... Dec. 15 Waters ... that SDMS Vision Publisher(TM) (v.7.1 SR4), an electronic ... Management System (SDMS), a secure electronic repository that ... to a centralized database and is used to ... certified compliant with the SAFE-BioPharma digital identity and ...
(Date:12/15/2009)... Medical, Inc. (Nasdaq: NXTM ), a leading ... a group of its home hemodialysis patients and ... conventional (non-dialysis) Caribbean cruise with their NxStage® System ... Freedom Cruise: We,re Taking Home Dialysis to Sea," ... and returns on January 10, 2010. The ...
Breaking Medicine Technology:Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 2Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 3Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 4Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 5Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 6Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 7Reportlinker Adds Surgical and Medical Instrument Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition] 8Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 2Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 3Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 4Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 5Waters SDMS Vision Publisher Now Certified Compliant with SAFE-BioPharma Digital Standard 6Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 2Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 3Group of NxStage(R) Home Hemodialysis Patients to Take Caribbean Cruise with the System One(TM) 4Researcher physician and teacher Phil Gold to be inducted into the Canadian Medical Hall of Fame 59813 1Researcher physician and teacher Phil Gold to be inducted into the Canadian Medical Hall of Fame 59813 2Researcher physician and teacher Phil Gold to be inducted into the Canadian Medical Hall of Fame 59813 3Press alert for American Society of Nephrologys 42nd Annual Meeting and Scientific Exposition 59810 1Press alert for American Society of Nephrologys 42nd Annual Meeting and Scientific Exposition 59810 2K State receives more than 24780 000 to fund graduate students studying ecology evolution genomics 10432 1K State receives more than 24780 000 to fund graduate students studying ecology evolution genomics 10432 2
(Date:12/15/2009)... but not delivered ,, WASHINGTON, Dec. 15 ... to ensure that healthcare reform does not override ... insurance companies in 37 states. ,, Prostate cancer ... the population and individuals who are identifiable as ... who have a family history of prostate cancer. ...
(Date:12/15/2009)... PARK, Calif., Dec. 15 ... position in the pharmaceutical and bio-tech research ... Marketing Research). Over the past 11 years ... the Physicians Consulting Network (PCN®), which now ... professionals covering both primary care and hard-to-reach ...
(Date:12/15/2009)... Team In Training (TNT), The Leukemia ... sports training program, has reached a remarkable milestone ... research and patient services. ,, For more than ... endurance sports training program, preparing amateurs and seasoned ... 100-mile century cycle ride or hike adventure. Through ...
(Date:12/15/2009)... Dec. 15 The following are the ... for the criminal division, at the Medicare Fraud ... Sebelius. And thank you for the enormous effort ... initiative. ,, Together, our Departments have and ... ,, We,ve made tremendous progress in fighting Medicare ...
(Date:12/15/2009)... North American application activity for individually underwritten life ... the MIB Life Index(SM) . Solid ... three months have lifted year-to-date (YTD) figures from ... at November,s close, -0.1%. "It is clear ... available from life insurance," says Stacy Gill, MIB ...
Breaking Medicine News(10 mins):Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 2Health News:Remarks by Lanny A. Breuer, Assistant Attorney General for the Criminal Division, at the Medicare Fraud Strike Force Press Conference 3Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 2Health News:MIB Life Index Reports North American Life Insurance Activity Up 3.9% in November 3
... MA -- Heavy alcohol use, or binge drinking, among college ... the college environment. That is one of the key findings ... Public Health College Alcohol Study (CAS), a landmark study that ... to 2001. In a new review that examines the findings ...
... ,gray matter, grew as they picked up juggling skills , , ... A new study among older would-be jugglers suggests the aging ... The finding is based on an analysis of brain scans ... of juggling. Although they typically picked up the skill less ...
... 11 The following is a joint,statement from ... reaction to the release of the Centers for ... Demonstration Program:, "The report shows that the ... payments from the Medicare Trust Fund over the ...
... BRAINTREE, Mass., July 11 Three major U.S. ... System in their,stores in September, marking the first-wave ... expected to be operating nationwide by this time,next ... period by a panel of 12 medical,and nutrition ...
... pharmaceutical,and healthcare company, said today a judge had refused ... its indictment of Goldshield Group,Plc and two of its ... defraud the Department of Health in relation to allegations,of ... refused the SFO,s application for permission to appeal., ...
... of breast cancer may benefit from receiving radiation therapy ... a study in the July issue of the International ... of the American Society for Therapeutic Radiology and Oncology. ... in the connective tissue of the breast, as opposed ...
Other Medicine News:Health News:Binge drinking tied to conditions in the college environment 2Health News:Binge drinking tied to conditions in the college environment 3Health News:Aging Brain Can Learn New Tricks 2Health News:Aging Brain Can Learn New Tricks 3Health News:RAC Companies Respond to CMS Report on RAC Demonstration Program 2Health News:NuVal(TM) Nutritional Scoring System Will Debut in Major U.S. Chains This September 2Health News:NuVal(TM) Nutritional Scoring System Will Debut in Major U.S. Chains This September 3Health News:Treating rare breast cancer with radiation therapy may lower recurrence rate 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: